ALBRIOZA Commercial Launch
Strong Global IP Position
Portfolio Provides Robust Protection of RELYVRIO and Related Combinations
59
issued patents worldwide
Patents and patent applications cover:
Composition of matter of the combination of PB and TURSO,
including in the U.S. - through 2033*
47
additional patents pending
+
many additional filings planned
FISH
FISH & RICHARDSON
•
-
And in some territories, the combination of
related compounds
Method of use of the combination and related combinations
for treating neurodegenerative disease
• Formulation of the combination and manufacturing process
• Methods of treating ALS based on clinical trial results -
through 2040
Five orange book listed patents directed to RELYVRIO and/or
its method of use
NCE exclusivity and Orphan exclusivity granted; protects
against generics (7 years in US, 10 in EU, 8 in Canada)
* Once approved in a jurisdiction, we plan to seek any applicable patent term extensions (PTE). PTE applications have been filed in the U.S.
AMYLYX 33View entire presentation